Format

Send to

Choose Destination
Diabetes Metab Res Rev. 2019 Aug 29:e3213. doi: 10.1002/dmrr.3213. [Epub ahead of print]

Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials.

Author information

1
Department of Clinical and Preventive Nutrition Sciences, School of Health Professions, Rutgers University, Newark, New Jersey.

Abstract

With the increasing prevalence of type 2 diabetes mellitus (T2DM), there is increased interest in probiotic supplementation for improving glycaemic control. This review evaluates nine randomized controlled trials that tested the effects of probiotics on glycaemic outcomes including fasting plasma glucose, fasting plasma insulin, haemoglobin A1c, and homeostatic model assessment of insulin resistance among adults with T2DM. Based on the evidence reviewed, multistrain probiotics that contain seven million to 100 billion colony forming units of Lactobacillus acidophilus, Streptococcus thermophilus, Lactobacillus bulgaricus, and/or Bifidobacterium lactis administered for 6 to 12 weeks may be efficacious for improving glycaemic control in adults with T2DM. Further research is needed to understand the role of the gut microbiota and the probiotic dose, medium, and duration of exposure that is most effective for disease management.

KEYWORDS:

diabetes mellitus; gastrointestinal microbiome; insulin resistance; metabolism; probiotics

PMID:
31465625
DOI:
10.1002/dmrr.3213

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center